MedTrace Logo

Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation

NCT01943812 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 287

Last updated 2020-06-23

No results posted yet for this study

Summary

The aim of this study is to compare two FET protocols by modifying the substituted FET cycle in order to maintain a higher ongoing positive pregnancy rate and thus reduce the early pregnancy loss.

Hypothesis: adding GnRH-agonist to the substituted cycle in FET treatment reduces the early pregnancy loss.

Conditions

  • Pregnancy Loss
  • Frozen Embryo Transfer

Interventions

DRUG

Estradiol and progeterone

Estradiol and progesterone

Sponsors & Collaborators

  • Peter Humaidan

    lead OTHER

Principal Investigators

  • Birgit Alsbjerg, M.D. · Fertility Clinic Regional Hospital Skive

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2019-04-30
Completion
2020-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01943812 on ClinicalTrials.gov